A randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors: A trial of the ECOG-ACRIN Cancer Research Group (E2211) Meeting Abstract
| Authors: | Kunz, P. L.; Catalano, P.; Nimeiri, H. S.; Fisher, G. A. Jr; Longacre, T. A.; Suarez, C. J.; Yao, J. C.; Kulke, M. H.; Hendifar, A.; Shanks, J. C.; Shah, M. H.; Zalupski, M. M.; Schmulbach, E.; Reidy-Lagunes, D. L.; Strosberg, J. R.; O'Dwyer, P. J.; Benson, A. |
| Abstract Title: | A randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors: A trial of the ECOG-ACRIN Cancer Research Group (E2211) |
| Meeting Title: | 11th Annual Meeting of the North American Neuroendocrine Tumor Society (NANETS) |
| Journal Title: | Pancreas |
| Volume: | 48 |
| Issue: | 3 |
| Meeting Dates: | 2018 Oct 4-6 |
| Meeting Location: | Seattle, WA |
| ISSN: | 0885-3177 |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2019-03-01 |
| Start Page: | 443 |
| Language: | English |
| ACCESSION: | WOS:000462541800082 |
| PROVIDER: | wos |
| DOI: | 10.1097/MPA.0000000000001250 |
| Notes: | Meeting Abstract -- Source: Wos |
